United States · FDA National Drug Code directory

Doxylamine Succinate and Pyridoxine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 49884-186_81f18ff6-274e-4134-8113-840407bee3dd
Product NDC: 49884-186
Form: TABLET, DELAYED RELEASE
Composition / generic term: Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg
Labeler: Par Health USA, LLC
Marketing category: ANDA
Marketing start / end (source format): 20191219
Source listing expiry: 20271231

Source-listed ingredients

DOXYLAMINE SUCCINATE — 10 mg/1
PYRIDOXINE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, DELAYED RELEASE in 1 BOTTLE (49884-186-01) · 49884-186-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →